Lytix Biopharma AS (OSL:LYTIX)
Norway
· Delayed Price · Currency is NOK 9.50
0.00 (0.00%)
Mar 9, 2026, 4:25 PM CET
Lytix Biopharma AS Market Cap
Lytix Biopharma AS has a market cap or net worth of 730.55 million as of March 9, 2026. Its market cap has increased by 107.41% in one year.
Market Cap
730.55M
Enterprise Value
660.39M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9.50
Market Cap Chart
Since June 14, 2021, Lytix Biopharma AS's market cap has increased from 720.55M to 730.55M, an increase of 1.39%. That is a compound annual growth rate of 0.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 730.55M | 8.32% |
| Dec 30, 2025 | 674.43M | 68.03% |
| Dec 30, 2024 | 401.38M | 106.12% |
| Dec 29, 2023 | 194.73M | -37.37% |
| Dec 30, 2022 | 310.93M | -41.63% |
| Dec 30, 2021 | 532.66M | -26.08% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 717.79M |
| Nykode Therapeutics AS | 1.03B |
| ArcticZymes Technologies ASA | 1.16B |
| Zelluna ASA | 409.70M |
| Thor Medical ASA | 1.54B |
| SoftOx Solutions AS | 155.87M |
| EXACT Therapeutics AS | 110.08M |
| Arctic Bioscience AS | 91.65M |